JPS62142175A - （―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法 - Google Patents
（―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法Info
- Publication number
- JPS62142175A JPS62142175A JP61266510A JP26651086A JPS62142175A JP S62142175 A JPS62142175 A JP S62142175A JP 61266510 A JP61266510 A JP 61266510A JP 26651086 A JP26651086 A JP 26651086A JP S62142175 A JPS62142175 A JP S62142175A
- Authority
- JP
- Japan
- Prior art keywords
- resinate
- ebrunamenin
- resin
- weight
- eburnamenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 230000003111 delayed effect Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000002798 polar solvent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 5
- 239000003729 cation exchange resin Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229940023913 cation exchange resins Drugs 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- VKTOXAGUZWAECL-MOPGFXCFSA-N (-)-eburnamenine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=CN5C2=C1 VKTOXAGUZWAECL-MOPGFXCFSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003509 long acting drug Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- VKTOXAGUZWAECL-UHFFFAOYSA-N trans-eburnamenine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=CN5C2=C1 VKTOXAGUZWAECL-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical class C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020375 flavoured syrup Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002362 mulch Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- WPKVKNZNPQRHOD-UHFFFAOYSA-N prop-1-ene Chemical group [CH2+]C=C WPKVKNZNPQRHOD-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES548735 | 1985-11-08 | ||
| ES548735A ES8604955A1 (es) | 1985-11-08 | 1985-11-08 | Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62142175A true JPS62142175A (ja) | 1987-06-25 |
| JPH0569837B2 JPH0569837B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-10-01 |
Family
ID=8490144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61266510A Granted JPS62142175A (ja) | 1985-11-08 | 1986-11-08 | （―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法 |
Country Status (7)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140505A (en) | 1995-03-10 | 2000-10-31 | G. D. Searle & Co. | Synthesis of benzo fused heterocyclic sulfonyl chlorides |
| CN103012645B (zh) * | 2012-11-27 | 2015-11-25 | 安徽皖东化工有限公司 | 高交换量强酸苯乙烯系阳离子交换树脂的生产方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2085630A1 (en) * | 1970-04-07 | 1971-12-31 | Le Men Georges | Vincamone compsn - having vasodilator ganglioplegic and antihistamine activity |
| JPS5762277A (en) * | 1980-06-23 | 1982-04-15 | Ciba Geigy Ag | Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE550150A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1955-08-08 | |||
| US3070503A (en) * | 1959-05-22 | 1962-12-25 | Merck & Co Inc | Pyrilamine resin absorbate with aspirin and/or ascorbic acid |
| GB877282A (en) * | 1959-06-01 | 1961-09-13 | Pfizer & Co C | Therapeutic composition and preparation thereof |
| US3138525A (en) * | 1961-06-16 | 1964-06-23 | Hoffmann La Roche | Castor wax-amprotropine-resin compositions |
| GB1191372A (en) * | 1967-05-09 | 1970-05-13 | Pfizer & Co C | Process for Novel Cyclic Amidines and their Non-Toxic Acid Addition Salts |
| GB1218102A (en) * | 1968-03-15 | 1971-01-06 | Philips Nv | Improvements in medicaments comprising drug/ion-exchange resin compounds |
| FR2253507A1 (en) * | 1973-12-11 | 1975-07-04 | Houdet Antoine | Vincamine administration using delayed release excipient - allowing prolonged action |
| US4359555A (en) * | 1979-06-29 | 1982-11-16 | Ciba-Geigy Corporation | Salts formed from formamidines with polymers containing sulfonic acid groups |
| US4369175A (en) * | 1981-07-27 | 1983-01-18 | Ciba-Geigy Corporation | Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them |
| CH655507B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1983-01-12 | 1986-04-30 |
-
1985
- 1985-11-08 ES ES548735A patent/ES8604955A1/es not_active Expired
-
1986
- 1986-11-05 GB GB868626441A patent/GB8626441D0/en active Pending
- 1986-11-06 FR FR8615469A patent/FR2589731B1/fr not_active Expired - Fee Related
- 1986-11-07 DE DE19863638064 patent/DE3638064A1/de not_active Ceased
- 1986-11-07 CH CH4407/86A patent/CH673281A5/de not_active IP Right Cessation
- 1986-11-07 GB GB8626656A patent/GB2184731B/en not_active Expired - Fee Related
- 1986-11-08 JP JP61266510A patent/JPS62142175A/ja active Granted
-
1988
- 1988-03-22 US US07/171,672 patent/US4929440A/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2085630A1 (en) * | 1970-04-07 | 1971-12-31 | Le Men Georges | Vincamone compsn - having vasodilator ganglioplegic and antihistamine activity |
| JPS5762277A (en) * | 1980-06-23 | 1982-04-15 | Ciba Geigy Ag | Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| ES8604955A1 (es) | 1986-03-16 |
| GB8626441D0 (en) | 1986-12-03 |
| GB2184731B (en) | 1990-06-13 |
| FR2589731B1 (fr) | 1995-09-29 |
| JPH0569837B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-10-01 |
| ES548735A0 (es) | 1986-03-16 |
| CH673281A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-02-28 |
| FR2589731A1 (fr) | 1987-05-15 |
| GB8626656D0 (en) | 1986-12-10 |
| US4929440A (en) | 1990-05-29 |
| DE3638064A1 (de) | 1987-05-27 |
| GB2184731A (en) | 1987-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4160827A (en) | Metronidazole phosphate and salts | |
| WO2003086357A1 (en) | Diphenhydramine tannate liquid and semi-solid compositions and methods of use | |
| JPH0144176B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| CZ229396A3 (en) | Oral liquid preparations containing paroxetin resinate | |
| JPS59134759A (ja) | 置換カルボン酸の樹脂酸塩、その製法およびこれを含有する鎮痛消炎剤組成物 | |
| CA1306949C (en) | Taste masking compositions | |
| AU599034B2 (en) | Furosemide salts | |
| EP0804168A1 (en) | Taste masked composition containing a drug/polymer complex | |
| JPH0248526A (ja) | インドメタシン注射剤およびその製造方法 | |
| US4971791A (en) | Taste masking compositions | |
| IE902829A1 (en) | Microencapsulated taste-masked water-insoluble nsaid drug¹materials | |
| JPS5929190B2 (ja) | スルホンアミド化合物 | |
| US4073895A (en) | Isopropylamino pyrimidine orthophosphate | |
| US20080095842A1 (en) | Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations | |
| AU2003235700B2 (en) | Stable salts of o-acetylsalicylic acid containing basic amino acids II | |
| JPS62142175A (ja) | （―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法 | |
| US3144387A (en) | Anti-inflammatory compositions | |
| IE51568B1 (en) | Vincamine saccharinate and pharmaceutical compositions containing same | |
| CA2136946C (en) | Oral decongestant product | |
| IE52909B1 (en) | Oxazole derivatives | |
| CA2469736A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
| JPS6396123A (ja) | ビタミンａ酸亜鉛塩を含有する抗炎症剤 | |
| US3459854A (en) | Tetracycline cyclohexyl sulphamate and process for preparation | |
| EP0087142B1 (en) | The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles | |
| JPH03206037A (ja) | 方法 |